Addition of a c-myc epitope tag within the VEGF protein does not affect in vitro biological activity

被引:7
作者
Chavand, O
Spilsbury, K
Rakoczy, PE
机构
[1] Univ Western Australia, Ctr Ophthalmol & Vis Sci, Nedlands, WA 6009, Australia
[2] Lions Eye Inst, Dept Mol Ophthalmol, Nedlands, WA 6009, Australia
关键词
vascular endothelial growth factor; VEGF; c-myc epitope tag; immunocytochemistry;
D O I
10.1139/bcb-79-1-107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The overexpression of vascular endothelial growth factor (VEGF) has been strongly implicated in diseases involving neovascularization. VEGF exists in as many as six different isoforms, each showing a unique pattern of tissue distribution and activity. To investigate the effect of individual VEGF isoform overexpression in neovascular disease models, we inserted c-myc epitope tags into the three VEGF isoforms expressed in retinal pigment epithelial cells, VEGF(121), VEGF(165), and VEGF(189). We found that the 12-amino acid insertion between the receptor binding and heparin binding domains did not affect VEGF transcription, translation, or secretion. In addition, VEGF isoforms containing the c-myc epitope tag were able to stimulate endothelial cell proliferation as efficiently as non-tagged VEGF isoforms and they could be individually identified by Western blotting and immunocytochemistry using the c-myc epitope specific monoclonal antibody 9E10.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 30 条
[1]  
AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178
[2]   Functional expression of tagged human Na+-glucose cotransporter in Xenopus laevis oocytes [J].
Bissonnette, P ;
Noël, J ;
Coady, MJ ;
Lapointe, JY .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 520 (02) :359-371
[3]  
Cañete-Soler R, 1999, J NEUROSCI, V19, P1273
[4]   STRUCTURAL REQUIREMENTS FOR DIMERIZATION, GLYCOSYLATION, SECRETION, AND BIOLOGICAL FUNCTION OF VPF/VEGF [J].
CLAFFEY, KP ;
SENGER, DR ;
SPIEGELMAN, BM .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1246 (01) :1-9
[5]  
DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955
[6]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[7]   ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT [J].
EVAN, GI ;
LEWIS, GK ;
RAMSAY, G ;
BISHOP, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3610-3616
[8]   Solution structure of the heparin-binding domain of vascular endothelial growth factor [J].
Fairbrother, WJ ;
Champe, MA ;
Christinger, HW ;
Keyt, BA ;
Starovasnik, MA .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (05) :637-648
[9]  
FAU H, 1998, BIOCH CELL BIOL, V76, P125
[10]  
GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093